Skip to main content

Table 3 Changes in clinical measures at 12 months between participants randomised to usual practice (control) or to the 3R intervention

From: Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial

Variable

Number of participants (%)

Mean (SD)

Adjusted difference at follow-up*

Control

Intervention

Control

Intervention

Coefficient (95% CI)

P value

BMI (kg/m2)

86 (80)

69 (66)

28.60 (5.15)

28.29 (4.64)

− 0.36 (− 0.77 to 0.05)

0.088

Body weight (kg)

86 (80)

69 (66)

80.41 (17.43)

79.88 (16.34)

− 0.99 (− 2.12 to 0.13)

0.084

Waist circumference (cm)

86 (80)

69 (66)

99.44 (13.96)

98.22 (13.13)

− 2.55 (− 4.55 to − 0.55)

0.013

Hip circumference (cm)

86 (80)

69 (66)

107.39 (10.63)

107.70 (9.75)

0.79 (− 1.14 to 2.73)

0.419

Systolic BP (mmHg)

86 (80)

69 (66)

141.93 (19.04)

137.55 (18.96)

− 4.19 (− 9.13 to 0.76)

0.096

Diastolic BP (mmHg)

86 (80)

69 (66)

85.00 (9.77)

80.52 (10.88)

− 4.28 (− 6.98 to − 1.58)

0.002

Total cholesterol (mmol/l)

86 (80)

69 (66)

5.46 (1.01)

5.21 (0.70)

− 0.21 (− 0.46 to 0.05)

0.120

HDL cholesterol (mmol/l)

86 (80)

69 (66)

1.65 (0.59)

1.63 (0.45)

0.01 (− 0.06 to 0.08)

0.814

TC-to-HDL ratio

86 (80)

69 (66)

3.59 (1.14)

3.44 (1.04)

− 0.18 (− 0.40 to 0.05)

0.128

CVD risk score

86 (80)

69 (66)

17.06 (10.30)

16.71 (9.20)

− 1.36 (− 3.28 to 0.56)

0.165

Number of prescriptions

99 (93)

92 (88)

10.80 (3.95)

11.82 (3.62)

0.98 (− 0.07 to 2.04)

0.067

  1. CI confidence interval
  2. *Adjusted difference at 12 months between treatment groups with 95% confidence interval, P value; adjusted for baseline value and stratification categories (age and sex)